Glenmark Pharmaceuticals
BSE 532296
4 stories, newest first.
- Glenmark Pharmaceuticals sets Q2 FY2027 earnings call for Nov 6, 2026, 8:30–9:30 am IST
- Board meeting on November 5 to consider and approve September quarter unaudited results
- Nomura retained buy call on Glenmark Pharma with stock up about 4.8%, raising target price to 3,750 rupees from 3,300 rupees
- US arm launches pump packs for Adapalene Gel USP, 0.1% (OTC)
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.